Psoriasis Plaque Test
Showing 1 - 25 of >10,000
Psoriasis Vulgaris Trial in Bergmannstrasse 5 (AKVANO-Calcipotriol formulation 1, AKVANO-Calcipotriol formulation 2, AKVANO
Completed
- Psoriasis Vulgaris
- AKVANO-Calcipotriol formulation 1
- +5 more
-
Bergmannstrasse 5, Berlin, Germanybioskin GmbH
Aug 3, 2022
Psoriasis Trial (BI 765250, Placebo)
Not yet recruiting
- Psoriasis
- BI 765250
- Placebo
- (no location specified)
Feb 6, 2023
Plaque Psoriasis Trial in Charlotte (Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%, Duobrii® Lotion (Halobetasol
Completed
- Plaque Psoriasis
- Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%
- +2 more
-
Charlotte, North CarolinaCatawba Research, LLC
Mar 15, 2022
Plaque Psoriasis Trial in Cairo (Bee venom phonophoresis)
Not yet recruiting
- Plaque Psoriasis
- Bee venom phonophoresis
-
Cairo, EgyptAhmed Mohamed Ahmed Abdelhady
Oct 31, 2023
Psoriasis Trial in Canada, Germany, United States (BI 730357, Placebo to match BI 730357)
Terminated
- Psoriasis
- BI 730357
- Placebo to match BI 730357
-
Birmingham, Alabama
- +29 more
Oct 27, 2022
Plaque Psoriasis Trial in Louisville (roflumilast cream 0.3%, Zoryve, Placebo)
Recruiting
- Plaque Psoriasis
- roflumilast cream 0.3%
- +2 more
-
Louisville, KentuckyDS Research
Feb 28, 2023
Tolerability in Pediatric Patients With Psoriasis
Not yet recruiting
- Moderate-to-severe Plaque Psoriasis
- Secukinumab
- (no location specified)
Nov 16, 2023
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial (Placebo, Bimekizumab)
Not yet recruiting
- Chronic Plaque Psoriasis
- Moderate to Severe Chronic Plaque Psoriasis
- Placebo
- Bimekizumab
- (no location specified)
Aug 21, 2023
Deucravacitinib in Moderate-to-Severe Plaque Psoriasis in
Recruiting
- Plaque Psoriasis
-
Selters, Rhineland-Palatinate, GermanyDermatologische Spezial- und Schwerpunktpraxis Selters
Oct 23, 2023
Psoriasis Trial in Lahore (Apremilast 30mg)
Completed
- Psoriasis
- Apremilast 30mg
-
Lahore, Punjab, PakistanGhurki Hospital
Sep 5, 2023
Clinical Study of Stage IV Psoriasis in Children With Geleli
Not yet recruiting
- Plaque Psoriasis
- (no location specified)
Mar 26, 2023
Stable Plaque Psoriasis Trial (LEO 90100, Daivobet® ointment)
Not yet recruiting
- Stable Plaque Psoriasis
- LEO 90100
- Daivobet® ointment
- (no location specified)
Jun 16, 2023
Psoriasis Vulgaris, Fractional CO2 Laser Trial in Assiut (Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone
Completed
- Psoriasis Vulgaris
- Fractional CO2 Laser
- Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm
- Fractional carbon dioxide (CO2) laser
-
Assiut, EgyptAssiut University
Aug 23, 2023
Plaque Psoriasis Trial in Karachi (Secukinumab Injection)
Completed
- Plaque Psoriasis
- Secukinumab Injection
-
Karachi, Sindh, PakistanJinnah Post graduate Medical centre
Jun 4, 2023
Moderate to Severe Chronic Plaque Psoriasis Trial (CT-P17, EU-approved Humira)
Not yet recruiting
- Moderate to Severe Chronic Plaque Psoriasis
- CT-P17
- EU-approved Humira
- (no location specified)
Aug 8, 2022
Moderate-to-severe Plaque Psoriasis Patients Response to
Completed
- Moderate-to-severe Plaque Psoriasis
-
Jakarta, IndonesiaMangga Besar Clinic
Mar 15, 2023
Psoriasis Trial in Shanghai (HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched tablets)
Not yet recruiting
- Psoriasis
- HS-10374 tablets 1mg
- +2 more
-
Shanghai, Shanghai, ChinaHuashan Hospital of Fudan University
Oct 8, 2023
